imalumab experimental monoclonal antibody macrophage inhibitory factor mif cytokine known exacerbate tumor january tested phase iia clinical trials metastatic colorectal developed cytokine pharmasciences baxalta purchased shire phase iii trial patients malignant ascites terminated monoclonal article stub help wikipedia expanding ithttpsenwikipediaorgwikiimalumab